Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis

OBJECTIVES: Gastroesophageal reflux disease (GERD) occurs frequently in patients with SSc. We investigated whether the presence of GERD and/or the use of anti-acid therapy, specifically proton-pump inhibitors (PPIs), are associated with long-term outcomes, especially in SSc-associated interstitial l...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreuter, Michael, Bonella, Francesco, Blank, Norbert, Riemekasten, Gabriela, Müller-Ladner, Ulf, Henes, Jörg, Siegert, Elise, Günther, Claudia, Kötter, Ina, Pfeiffer, Christiane, Schmalzing, Marc, Zeidler, Gabriele, Korsten, Peter, Susok, Laura, Juche, Aaron, Worm, Margitta, Jandova, Ilona, Ehrchen, Jan, Sunderkötter, Cord, Keyßer, Gernot, Ramming, Andreas, Schmeiser, Tim, Kreuter, Alexander, Kuhr, Kathrin, Lorenz, Hanns-Martin, Moinzadeh, Pia, Hunzelmann, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473195/
https://www.ncbi.nlm.nih.gov/pubmed/36708008
http://dx.doi.org/10.1093/rheumatology/kead023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473195/
https://www.ncbi.nlm.nih.gov/pubmed/36708008
http://dx.doi.org/10.1093/rheumatology/kead023

Ejemplares similares